608 related articles for article (PubMed ID: 31802122)
1. The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.
Fountoulakis KN; Yatham LN; Grunze H; Vieta E; Young AH; Blier P; Tohen M; Kasper S; Moeller HJ
Int J Neuropsychopharmacol; 2020 Apr; 23(4):230-256. PubMed ID: 31802122
[TBL] [Abstract][Full Text] [Related]
2. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
Fountoulakis KN; Yatham L; Grunze H; Vieta E; Young A; Blier P; Kasper S; Moeller HJ
Int J Neuropsychopharmacol; 2017 Feb; 20(2):121-179. PubMed ID: 27816941
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant bipolar depression: towards a new definition.
Pacchiarotti I; Mazzarini L; Colom F; Sanchez-Moreno J; Girardi P; Kotzalidis GD; Vieta E
Acta Psychiatr Scand; 2009 Dec; 120(6):429-40. PubMed ID: 19740127
[TBL] [Abstract][Full Text] [Related]
6. Prepubertal bipolar disorder: available pharmacological treatment options.
Masi G
Expert Opin Pharmacother; 2005 Apr; 6(4):547-60. PubMed ID: 15934881
[TBL] [Abstract][Full Text] [Related]
7. Treatment guidelines for bipolar disorder: a critical review.
Fountoulakis KN; Vieta E; Sanchez-Moreno J; Kaprinis SG; Goikolea JM; Kaprinis GS
J Affect Disord; 2005 May; 86(1):1-10. PubMed ID: 15820265
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
Hamrin V; McDonnell MA; Moffett J; Durso S
Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
[TBL] [Abstract][Full Text] [Related]
9. Methodological differences between pharmacological treatment guidelines for bipolar disorder: what to do for the clinicians?
Samalin L; Guillaume S; Courtet P; Abbar M; Lancrenon S; Llorca PM
Compr Psychiatry; 2013 May; 54(4):309-20. PubMed ID: 23153855
[TBL] [Abstract][Full Text] [Related]
10. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.
Fountoulakis KN; Grunze H; Vieta E; Young A; Yatham L; Blier P; Kasper S; Moeller HJ
Int J Neuropsychopharmacol; 2017 Feb; 20(2):180-195. PubMed ID: 27941079
[TBL] [Abstract][Full Text] [Related]
11. Decision tree for the treatment of bipolar disorder.
Sachs GS
J Clin Psychiatry; 2003; 64 Suppl 8():35-40. PubMed ID: 12892540
[TBL] [Abstract][Full Text] [Related]
12. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
13. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
Hamrin V; Pachler M
J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
[TBL] [Abstract][Full Text] [Related]
14. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research.
Fountoulakis KN; Vieta E; Young A; Yatham L; Grunze H; Blier P; Moeller HJ; Kasper S
Int J Neuropsychopharmacol; 2017 Feb; 20(2):196-205. PubMed ID: 27677983
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
Fountoulakis KN; Vieta E
Int J Neuropsychopharmacol; 2008 Nov; 11(7):999-1029. PubMed ID: 18752718
[TBL] [Abstract][Full Text] [Related]
16. Defining the bipolar spectrum and treating bipolar II disorder.
Vieta E
J Clin Psychiatry; 2008 Apr; 69(4):e12. PubMed ID: 18507485
[TBL] [Abstract][Full Text] [Related]
17. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bipolar disorder.
Möller HJ; Nasrallah HA
J Clin Psychiatry; 2003; 64 Suppl 6():9-17; discussion 28. PubMed ID: 12720475
[TBL] [Abstract][Full Text] [Related]
19. The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.
Fountoulakis KN; Young A; Yatham L; Grunze H; Vieta E; Blier P; Moeller HJ; Kasper S
Int J Neuropsychopharmacol; 2017 Feb; 20(2):98-120. PubMed ID: 27815414
[TBL] [Abstract][Full Text] [Related]
20. Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder.
McDonald C
Curr Neuropharmacol; 2015; 13(4):445-57. PubMed ID: 26412064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
